Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Viasat Bolsters Board with Two New Directors

Viasat added two new directors to its board and strategic review committee and reached an agreement with Carronade Capital Management.

The company appointed Shekar Ayyar, chairman and chief executive officer of Arrcus, and Jinhy Yoon, formerly an executive vice president at Pimco, effective immediately. With those additions, Viasat’s board now has 10 directors, 8 of them independent.

The move comes alongside a cooperation agreement with Carronade Capital, which said it has held constructive talks with Viasat over the past year. Under the agreement, Carronade accepted customary standstill and voting provisions.

Mark Dankberg, Viasat’s chairman and chief executive officer, said the board is continuing to focus on the company’s strategy and the service entry of the Viasat-3 constellation.

Ayyar brings operating and M&A experience from roles at VMware and Arrcus. He also served on Altair Engineering’s board through its sale to Siemens for more than $10 billion.

Yoon brings capital allocation and debt-market experience. At Pimco, she spent 14 years and oversaw about $30 billion in debt and equity investments. She also served on Intelsat’s board and helped guide its sale to SES in July 2025.

Carronade, a Darien, Connecticut-based investment firm founded in 2019, said it manages about $3.5 billion in assets and has 17 team members. Its founder, Dan Gropper, said the firm sees value in Viasat’s defense and advanced technologies business and its global MSS spectrum position. As a result of these announcements, the company's shares have moved -0.43% on the market, and are now trading at a price of $67.01. For the full picture, make sure to review VI's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS